Astrana Health Statistics

Total Valuation

Astrana Health has a market cap or net worth of EUR 951.52 million. The enterprise value is 1.30 billion.

Market Cap	951.52M
Enterprise Value	1.30B

Important Dates

The next estimated earnings date is Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	50.16M
Shares Outstanding	n/a
Shares Change (YoY)	+2.59%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	12.53%
Owned by Institutions (%)	53.73%
Float	37.71M

Valuation Ratios

The trailing PE ratio is 117.06 and the forward PE ratio is 10.51.

PE Ratio	117.06
Forward PE	10.51
PS Ratio	0.39
PB Ratio	2.01
P/TBV Ratio	n/a
P/FCF Ratio	11.51
P/OCF Ratio	10.48
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.13, with an EV/FCF ratio of 15.71.

EV / Earnings	159.68
EV / Sales	0.52
EV / EBITDA	11.13
EV / EBIT	18.12
EV / FCF	15.71

Financial Position

The company has a current ratio of 1.40, with a Debt / Equity ratio of 1.96.

Current Ratio	1.40
Quick Ratio	1.36
Debt / Equity	1.96
Debt / EBITDA	8.14
Debt / FCF	11.21
Interest Coverage	2.01

Financial Efficiency

Return on equity (ROE) is 1.83% and return on invested capital (ROIC) is 3.87%.

Return on Equity (ROE)	1.83%
Return on Assets (ROA)	2.88%
Return on Invested Capital (ROIC)	3.87%
Return on Capital Employed (ROCE)	5.06%
Revenue Per Employee	1.30M
Profits Per Employee	4,278
Employee Count	1,900
Asset Turnover	1.64
Inventory Turnover	n/a

Taxes

In the past 12 months, Astrana Health has paid 17.44 million in taxes.

Income Tax	17.44M
Effective Tax Rate	67.76%

Stock Price Statistics

The stock price has decreased by -52.96% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-52.96%
50-Day Moving Average	19.72
200-Day Moving Average	27.79
Relative Strength Index (RSI)	48.55
Average Volume (20 Days)	8

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.51

Income Statement

In the last 12 months, Astrana Health had revenue of EUR 2.47 billion and earned 8.13 million in profits. Earnings per share was 0.17.

Revenue	2.47B
Gross Profit	253.10M
Operating Income	69.25M
Pretax Income	25.74M
Net Income	8.13M
EBITDA	101.19M
EBIT	69.25M
Earnings Per Share (EPS)	0.17

Full Income Statement

Balance Sheet

The company has 395.00 million in cash and 926.66 million in debt, giving a net cash position of -531.66 million.

Cash & Cash Equivalents	395.00M
Total Debt	926.66M
Net Cash	-531.66M
Net Cash Per Share	n/a
Equity (Book Value)	472.79M
Book Value Per Share	13.38
Working Capital	216.23M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 90.80 million and capital expenditures -8.16 million, giving a free cash flow of 82.64 million.

Operating Cash Flow	90.80M
Capital Expenditures	-8.16M
Free Cash Flow	82.64M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 10.25%, with operating and profit margins of 2.81% and 0.33%.

Gross Margin	10.25%
Operating Margin	2.81%
Pretax Margin	1.04%
Profit Margin	0.33%
EBITDA Margin	4.10%
EBIT Margin	2.81%
FCF Margin	3.35%

Dividends & Yields

Astrana Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	59.19%
Buyback Yield	-2.59%
Shareholder Yield	-2.59%
Earnings Yield	0.85%
FCF Yield	8.69%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Astrana Health has an Altman Z-Score of 2.34 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.34
Piotroski F-Score	5